Sinopharm Group Co. Ltd. (OTCMKTS:SHTDF – Get Free Report) was the recipient of a large growth in short interest in the month of April. As of April 30th, there was short interest totaling 6,820,757 shares, a growth of 269.2% from the April 15th total of 1,847,289 shares. Based on an average trading volume of 295 shares, the short-interest ratio is presently 23,121.2 days.
Sinopharm Group Price Performance
SHTDF opened at $2.33 on Thursday. The company has a fifty day moving average price of $2.59 and a two-hundred day moving average price of $2.53. Sinopharm Group has a 52 week low of $2.11 and a 52 week high of $2.70.
About Sinopharm Group
Sinopharm Group Co, Ltd is one of China’s largest state-owned integrated healthcare companies, primarily focused on the research, development, production and distribution of a broad range of pharmaceutical and healthcare products. Established in 1998 through the reorganization of assets under China National Pharmaceutical Group (Sinopharm), the company has grown to encompass multiple business segments, including prescription medicines, over-the-counter drugs, vaccines and medical devices. Sinopharm Group is listed on the Hong Kong Stock Exchange and trades in the United States through its OTCMKTS ticker SHTDF.
The company’s product portfolio spans chemically synthesized drugs, biologics and traditional Chinese medicine formulations, supported by an extensive nationwide manufacturing and quality-control network.
Featured Stories
- Five stocks we like better than Sinopharm Group
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Sinopharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinopharm Group and related companies with MarketBeat.com's FREE daily email newsletter.
